RemeGen Completes Share Buyback After First Repurchase

MT Newswires Live01-21

RemeGen (HKG:9995, SHA:688331) has completed its share repurchase plan after buying back 194,144 of its China-listed shares for about 20 million yuan, according to a Wednesday Hong Kong bourse filing.

The biopharmaceutical company repurchased the shares on Jan. 20 through centralized bidding at prices ranging from 102.17 yuan to 103.78 yuan per share. The repurchased shares represented about 0.03% of its total issued share capital.

The buyback reached the lower end of the approved repurchase amount of 20 million yuan to 40 million yuan, bringing the repurchase plan to completion, the company said.

The repurchased shares will be held in a dedicated securities account and are intended for future employee stock ownership plans or equity incentives, the filing showed.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment